Earnings Feed
Start Free
Home/Insiders/Lynton Nicholas Hollmeyer
LN
SEC Insider//CIK 0001941467

Lynton Nicholas Hollmeyer

CIK 00019414671 companyATLANTA, GA
SEC Profile

Transactions

50

Companies

1

Filings

3

CIK

0001941467

Recent Transactions

50 trades
  • Sale
    Cardlytics, Inc.$CDLX

    Common Stock

    2026-01-05$1.17/sh−6,253→ 122,862 total
  • Exercise/Conversion
    Cardlytics, Inc.$CDLX

    Restricted Stock Units

    2026-01-01−1,578→ 3,156 total
  • Exercise/Conversion
    Cardlytics, Inc.$CDLX

    Restricted Stock Unit

    2026-01-01−581→ 582 total
  • Exercise/Conversion
    Cardlytics, Inc.$CDLX

    Restricted Stock Unit

    2026-01-01−10,629→ 10,630 total
  • Exercise/Conversion
    Cardlytics, Inc.$CDLX

    Common Stock

    2026-01-01+10,629→ 129,115 total
  • Exercise/Conversion
    Cardlytics, Inc.$CDLX

    Common Stock

    2026-01-01+1,578→ 118,486 total
  • Exercise/Conversion
    Cardlytics, Inc.$CDLX

    Common Stock

    2026-01-01+581→ 116,908 total
  • Sale
    Cardlytics, Inc.$CDLX

    Common Stock

    2025-10-02$2.27/sh−6,098→ 116,327 total
  • Exercise/Conversion
    Cardlytics, Inc.$CDLX

    Common Stock

    2025-10-01+581→ 120,847 total
  • Exercise/Conversion
    Cardlytics, Inc.$CDLX

    Common Stock

    2025-10-01+1,578→ 122,425 total
  • Exercise/Conversion
    Cardlytics, Inc.$CDLX

    Restricted Stock Unit

    2025-10-01−10,630→ 21,259 total
  • Exercise/Conversion
    Cardlytics, Inc.$CDLX

    Restricted Stock Units

    2025-10-01−1,578→ 4,734 total
  • Exercise/Conversion
    Cardlytics, Inc.$CDLX

    Restricted Stock Unit

    2025-10-01−581→ 1,163 total
  • Exercise/Conversion
    Cardlytics, Inc.$CDLX

    Common Stock

    2025-10-01+10,630→ 120,266 total
  • Sale
    Cardlytics, Inc.$CDLX

    Common Stock

    2025-07-02$1.78/sh−5,271→ 109,636 total
  • Exercise/Conversion
    Cardlytics, Inc.$CDLX

    Common Stock

    2025-07-01+581→ 113,329 total
  • Exercise/Conversion
    Cardlytics, Inc.$CDLX

    Restricted Stock Unit

    2025-07-01−10,629→ 31,889 total
  • Exercise/Conversion
    Cardlytics, Inc.$CDLX

    Restricted Stock Unit

    2025-07-01−581→ 1,744 total
  • Exercise/Conversion
    Cardlytics, Inc.$CDLX

    Common Stock

    2025-07-01+1,578→ 114,907 total
  • Exercise/Conversion
    Cardlytics, Inc.$CDLX

    Restricted Stock Units

    2025-07-01−1,578→ 6,312 total
  • Exercise/Conversion
    Cardlytics, Inc.$CDLX

    Common Stock

    2025-07-01+10,629→ 112,748 total
  • Award
    Cardlytics, Inc.$CDLX

    Performance Stock Unit

    2025-06-23+9,375→ 9,375 total
  • Award
    Cardlytics, Inc.$CDLX

    Restricted Stock Units

    2025-06-23+25,000→ 25,000 total
  • Sale
    Cardlytics, Inc.$CDLX

    Common Stock

    2025-04-22$1.51/sh−303→ 102,119 total
  • Exercise/Conversion
    Cardlytics, Inc.$CDLX

    Common Stock

    2025-04-20+682→ 102,422 total
  • Exercise/Conversion
    Cardlytics, Inc.$CDLX

    Restricted Stock Units

    2025-04-20−682→ 0 total
  • Sale
    Cardlytics, Inc.$CDLX

    Common Stock

    2025-04-02$1.81/sh−5,754→ 101,740 total
  • Exercise/Conversion
    Cardlytics, Inc.$CDLX

    Common Stock

    2025-04-01+1,578→ 107,494 total
  • Exercise/Conversion
    Cardlytics, Inc.$CDLX

    Restricted Stock Unit

    2025-04-01−10,629→ 42,518 total
  • Exercise/Conversion
    Cardlytics, Inc.$CDLX

    Common Stock

    2025-04-01+581→ 105,916 total
  • Exercise/Conversion
    Cardlytics, Inc.$CDLX

    Restricted Stock Unit

    2025-04-01−581→ 2,325 total
  • Exercise/Conversion
    Cardlytics, Inc.$CDLX

    Restricted Stock Units

    2025-04-01−1,578→ 7,890 total
  • Exercise/Conversion
    Cardlytics, Inc.$CDLX

    Common Stock

    2025-04-01+10,629→ 105,335 total
  • Award
    Cardlytics, Inc.$CDLX

    Restricted Stock Unit

    2025-03-19+120,000→ 0 total
  • Award
    Cardlytics, Inc.$CDLX

    Performance Stock Unit

    2025-03-19+45,000→ 0 total
  • Sale
    Cardlytics, Inc.$CDLX

    Common Stock

    2025-01-30$3.19/sh−3,377→ 94,706 total
  • Award
    Cardlytics, Inc.$CDLX

    Performance Stock Unit

    2025-01-29+6,312→ 6,312 total
  • Exercise/Conversion
    Cardlytics, Inc.$CDLX

    Common Stock

    2025-01-29+6,312→ 98,083 total
  • Exercise/Conversion
    Cardlytics, Inc.$CDLX

    Performance Stock Unit

    2025-01-29−6,312→ 0 total
  • Sale
    Cardlytics, Inc.$CDLX

    Common Stock

    2025-01-03$3.67/sh−6,464→ 91,771 total
  • Exercise/Conversion
    Cardlytics, Inc.$CDLX

    Common Stock

    2025-01-01+10,630→ 98,235 total
  • Exercise/Conversion
    Cardlytics, Inc.$CDLX

    Restricted Stock Unit

    2025-01-01−582→ 2,906 total
  • Exercise/Conversion
    Cardlytics, Inc.$CDLX

    Restricted Stock Units

    2025-01-01−1,578→ 9,468 total
  • Exercise/Conversion
    Cardlytics, Inc.$CDLX

    Common Stock

    2025-01-01+582→ 86,027 total
  • Exercise/Conversion
    Cardlytics, Inc.$CDLX

    Restricted Stock Unit

    2025-01-01−10,630→ 53,147 total
  • Exercise/Conversion
    Cardlytics, Inc.$CDLX

    Common Stock

    2025-01-01+1,578→ 87,605 total
  • Sale
    Cardlytics, Inc.$CDLX

    Common Stock

    2024-10-02$3.08/sh−5,936→ 85,445 total
  • Exercise/Conversion
    Cardlytics, Inc.$CDLX

    Restricted Stock Units

    2024-10-01−1,578→ 22,091 total
  • Exercise/Conversion
    Cardlytics, Inc.$CDLX

    Common Stock

    2024-10-01+10,629→ 91,381 total
  • Exercise/Conversion
    Cardlytics, Inc.$CDLX

    Common Stock

    2024-10-01+1,578→ 80,752 total

Companies

1

Recent Filings

3

Address

675 PONCE DE LEON AVENUE NE SUITE 4100

ATLANTA, GA, 30308

View on SEC.gov